USA cancer falls: better detection, better drugs

20 February 2006

The American Cancer Society has listed improvements in detection and treatment, as well as a reduction in smoker numbers, as the reasons for the first recorded fall in the USA's cancer deaths since the 1930s. The rate of deaths has been falling since the early 1990s, but the aging popu-lation meant that the overall figure continued to rise.

Early-diagnosed breast cancer five-year survival rates have increased from 80% in the 1950s to 98%. In 2003, the ACS states that there were 556,902 cancer deaths, a fall of 369 on the previous year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight